pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4793 |
Genomic Coordinates | chr3: 48644194 - 48644280 |
Description | Homo sapiens miR-4793 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4793-3p | |||||||||||||||
Sequence | 58| UCUGCACUGUGAGUUGGCUGGCU |80 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MAP3K9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | MEKK9, MLK1, PRKE1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | mitogen-activated protein kinase kinase kinase 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_033141 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on MAP3K9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of MAP3K9 (miRNA target sites are highlighted) |
>MAP3K9|NM_033141|3'UTR 1 CACGAAAAGGATTGGGGCGGGCAAGGGGGACAGCCAGCGGAGATGAGGGGAGCTGGCGGGCACAGCCCTTTCTCAGGGTT 81 GGACCCCCTGAGATCCAGCCCTACTTCTTGCACTGATAATGCACTTTGAAGATGGAAGGGATGGAAACAGGGCCACTTCA 161 GAGGGTCTCCTGCCCTGCAGGGCCTTTCTACCCGTGTCCACTGGAGGGGCTGTGGCCATCAGCTCTGGCTGTGTAGGGGA 241 GGAAGGGGTGCATGCATGTCCCCCACCCTCCACAGTCTTCCTTGCCTTTAGAGTGACCCTGCAGAGTCACTCAGCCAAAT 321 CTGTCTGCTGCTCCCTCTCCTCAGCCAGTTGGGTGTGCGCAGAGCTGTCATAGGGTCCCTTTGTCAGCCCCGAGTTCAGC 401 TTCCCAAACACCAGTGTTGGATATTCTGTGATTGATTTTGGTCCTCCTCCGCTGTCCCCCAACACCCAGGAATGGGAATC 481 TGGCTTGGTTCGAGATAGGAGCTTTTCTGTGTCCTAAGCCCTTTCATGCTAGCAGGAAGACTGAAAGCAAGGTGGCCCAG 561 TGTGGGGTCATAGGGCTTGATAGACCTGGCACTGCCTATCTGCACTTCCAGGTGCCCCACCTATTTATCTGAGCCCACAG 641 GTGGAAAGGGGAACTGCCTCAGTGAGAACGGGGGGACGGGGATGTTAGGAAAAATACAGTAAAGTTGCAATGAAGAGGTT 721 CATGAAGTATGTCCTTGTTCTTTTTGGAAACTCTCGGCAAAGGGCAAACCAGCAAGTATTGAGGGTACCCATCTAGCTAC 801 TTGGGGTCAGGACCTCGTCAGACCAGGTTCGGATACAATCATCTGCTCATCCCAGGAATAGTTTCTTGGGGGACTCACTC 881 ACTGGTGCCAGTTCTAAGTCAGAGACAAAATTCCACTGTCTGTTCCTTTTGCTGTCTGAACTTTATGTGTTACTCCCTTC 961 CTTTGGTCTTCACTCTAATCCCTGGAGTTTGTGGGCTTTTGGTTATGTTTGGTTAGTAGATATCACCGCAATGCCCTAGA 1041 ACAGCTATGAAGCAGAATACCATATGGCCACCTGGACATTGGGACTTGGGAATTCACTCTCAACTGGGCCATCCATGTTG 1121 TGATGCCCTTGAAGTAAAATGGAGCCAGCAGGAGTACCTTCTGTAAATGCATGTGGCAAAGTGCTATTTATAGGGTGCCC 1201 AGGGAGCCGCTGATGTACAATAACCTTGAGGTCCCCCATACTGAAAACTGACCAAGGCCTGTGCACAGGTAGCCCCTCAT 1281 GCTGGGCTCTGGACCATGAGCTGAGTAGGAAGGATAGCAGAGGCCAACCCTGACCTTCCTGGAAGTTGTTTCCTTAACTT 1361 GAATGTTGAGCTTCCTCTAAAGCTTTCTCGTGTATGTCTTCTCCATGCCACTACTCTGAGGCCTCCTGTGTTATGTGTGA 1441 ACAGTTGTCTTTATGTGGGAATGACGACTTGATTGGGAGTAGAGTCTCAAGGTCATTCCCCTCTTCCCTCAAGACTCTCT 1521 GAATGCTGCTCCACTGTCTTTTGTCTTGGAGGTCACTCAGCAGGTTCCTTGCATTTGCTGCCTGGATGTGCAGCTGGCAA 1601 CAGTGATGAATTGGTCACTGCTCTTTCTCTATAACTGGGATAGATGTCCTGCCTTGGGGTCACTAAAGGGGTGACCTTGT 1681 TCCTTGCTTTATGAGCCCATTAGCACTTTGGTTCAAGGGGCCCACCAAGTCTTGGACGGGAAGGCGCTACTGGTTTTATT 1761 GCCCAAGGTTTTGTTATTGCTTCTCTTCTGTGTCCTTCTCTTTGTTCAGTGAAGCCAATATGTAAGATACTGTTTTTGTC 1841 CCCATTCCCCTACTCCTGAGCTAGGAGGAAAAAATGTGAATCTTACCAGCAGTTCCAGCCAACCAAGTGATTCTTCTTCA 1921 TTCTTGATGGGGAGAAGTACATACAAAGTTTGTTCTGACAGGGCGCGGTGGCTCACGCCTGTAATCCCAGCGCTTTGGGA 2001 GGCAGAGGCAGGTGGATCACCTGAGGTCGGGAGTTCGAGACCAGCCTGACCAACATGGAGATATCCTGTCTCTACTAAAA 2081 ATACAAAAAAATTAGCCAGGCATGGTGGCACGTGCCTGTAATCCCAGCTACTCGCAAGGCTGAGGCAGGAGAATCGCTTG 2161 AACCTGGGAGGCGGAGGTTGCAGTGAGCCAAGATTGCGCCATTGCACTCCAGCCTGGGCAACAAGAGAGAAACTCTGTCT 2241 CAAAAAAAAAAAAAAAAAAAAAAAAAGTCTGTTCTGTGGCCTCCTTCCCCCGGGCCCTCCATAACCTCAGGCTAAACCAT 2321 GAGCACATCTGTATATCCTTGGCTCCACTAAATGGCCCTCTTGTGGCCCTCCAAACCATGCTGCCTATACACAGTGCTCT 2401 GTGGTATGAAGCAGAGATTTTTCCTTTGCTCATTTTTAACTTTTGCCATTGTGGTAGGTTGCAGCCATCTTTCTAGATGT 2481 AGTGTAACTGATGTAGTGTAACTGAATGATGGTCACCTGCCATTGAGTGAGAGGTTGAGTGCCATCCTTACTTGTCCACT 2561 GTGGGGAAAGATAAAGCAAGCCTGGGTCTTTGCTAAGGAAATAATTGTACCTGAAAGAAGCAAAAGCAGGGCTATCCAAA 2641 GGTGCTACTGTGAGCATCCATGAAGAAGGAACAGTTACCATCTCTCAGCTCCTACACACCTGGTCTCTGATGGGCCCCTG 2721 ACTGCTGCACTCTCTCAGTGGGGCAAGGTTGGAGATGGGCTAAGGATCTGTATAGTAGTAGCAGGTCTCAGTGGCTTTCT 2801 ATTCGCTCAGGTTCCCTTGTTCTGTGGTCCTGGTCGGGAGCAGGCCCTGGAGCTGTGGATGAAGCCACTTGAGTGGCAGT 2881 AGCCGGCCCCCCTTTCCTCTGCCTTCCCTTTGCACAAAGACACGTTCCTTCTGCTCTTGGCAGGTGCTAACTTCATGGAA 2961 GATGGTAATAGGAACAGATACTGCTCTCTGCCCCTGCTTCTTGGATTCTTCAGCTCCTACCGCTGATTCGGATTATCCCC 3041 TTTTGACCCTCTTGGGGATCCAGACTGCTGCCAGGAGGCTGAGTAGATACCTCAGTTATCTGTATGTTATTTCTGAGAGG 3121 CTTTGGCGGATCCTCTTCACTTGGCATCCTGTGGCATCCCTAGGGTCTGGTGGTAGCAGTAATAGCAACAATGATATCTT 3201 ACATCTGGACAACTCAGAATAGTGCTAACTTTTCCTCCTGACCTTTGCAAAATGACATCATTTTCCTTGTACATTTGATA 3281 CCCTTGCTAGTAGAGAAGGGGAAATGCTTAAAGATGAAAATTCAAGTGAAGAGAAATGAAAAAGTGGCTTGGACTAATTG 3361 CTGAGTGAGGCCACTGGGCTCAGAACTGAACAGGTTGGCTGCATTCCCCATTCTGCTTTTGCTGTGTGGCCATAGGCTTG 3441 TCTCTTTAGCCCCTCTCAGATTTCCTTCCTTTAAAAGCAATCATCACATGCTTTCCTCTCAAGGGAGTTGGGTGTATGTA 3521 TCAGAGAAGGTCAGTGAAACACCATAGCTCCTTGCCAGCTCCTAGAGGAAGCTTCTTTCATCTATACAGGATGAATCGCT 3601 GAAGTTGAGAGTGTGGCTCTCATCACCTTTGCCTTGAGGGAACTTGCCTTTTCTTTCGTCCTTTGGCTTCTGGAAGAGGA 3681 GTGATTTGGAGGTGGTTGAGCATGACTAATGGGGGCCCTGGTCGGGCCCATGCCCTTCTGCCGCATTTATATAGCATCTG 3761 GTGTTGACAAGCATTCTTTCCTAATTCCCCCACTTAACTTGTCTGATGCTGTCTGCCAATGTCATCCTCACCACTTGTGT 3841 CTTACAGAGAAGGAAATGGGAGAGGGAGGTTGTGTCTTACAGAGAAGGAAATGAGAGAGGGAGGTTGGTAGCAACATCAG 3921 AGTGACAGTTGGCTGTCTCTCATTTCTTGGGGTCATCAGTCTGATTTGTTTAGAGCCTGGGATCATCCCAGTTCCTGGAA 4001 GAATCTTTGGAAAAGGGTCCCCTTGTTCTTGGGACATGTGTCATGGTCACTAAGCCCCCTTTCCCTCAGGCTACTGTTGC 4081 TCAGGGACACAATGAGATACCCCAAGGACATCTAGACCTGACTTTTCATGAACTCTCTTGCCTCTGTGGTCCCCACATTG 4161 GAGACCTCCCTCCCTCCTCCTTCCCTTGTGTGAAGGAGACACCTCCCGAGCAATCCTAACTCATCCAGCTCACTTTTAAC 4241 AAAGCAAAGAGCAGAGGGCACTGAAGACTGGATGGCTGTGAATGGTACACCTTGGGGTTGAAACCGTGTTGGCAGGAACC 4321 TGGTGATAAAAGCTGCCTACTTCCTGGGTGTGTGAATTTGCACATATCTTTTCCCCTCACTGGACTTCAGAAGCCTACTG 4401 TGAACTGGGGACGATGCTATCTACTTTCCCTCCTGAAGCCCTTCTAACTTTCAAATGTATGGTCCTGGGGCCATGAGTCC 4481 TGCACAGAAACTGCAGCCTTGCCAGATTGCTTCCCTTGGTGCAGAAAAGTGTGTGTGTGTGTGTGTGTGAAATATACGTA 4561 CGGTTTTACGTCAAAAACAGTCGAATATCAGCTATTTCATATGGTTCACCCTAATGTACCTGCCTCTCTCTTTGGCTTTA 4641 GGTCTGAGAATGACTTGTCTTTGTCAAGGTATACTATTGTTAGAAACGCATTACCAAATGCATCTCTTCTGTCGGATCAG 4721 CGTATTCCTAGATTAGGAATTCAAATTAATGAAAATTCACATATGAAAGGAAAATCCATTGCTATTTCTGGAGAGGACCT 4801 CAGTCCTGGGCTTTTCCCTGGCATTGCTACCTGGGTGGGTGCTCACCACTCAGGTGCTGGTGTTGGAAGGCAGGAGGAGG 4881 AAGCTGAAATCCTGCCGATTAAGGCTAATTAACAGGGTTTAGGTGCCTAATTATCATGACTCAGCCCGGGACTTATGGTT 4961 AGCCGTGCAGGCCAGGTGAGTCTCTTATGGACTTCCTCTCAGACTGCTCTTTCTCATTTTGTCCTGATGAGATATTGACA 5041 GTCATGTCCACCCGCTTCCTCATCCATTTCCCGTCTTGGGCCCTGGAAGTACGGGGGCCTCTGTAGGCTGCCTAGGGAGC 5121 CCTGGCTTTGCTCTTCGTGTTGGGCTCACTCCATGATCAGGAGCCGGTGGGACTGGTCCTTCCTGATTCTTACTGTCTGT 5201 GGTTCCCCATCCCCTACGGGGAGCCTGCTTTGGGCCTTGAGCTGGATAGAGAGAAGAGCTTTGGGGCCCAGCTGGTTATA 5281 GGAGCTGAGCTTTTCCACACCTCTCTTTGTTAACCCTTGGAAACAGACCTGCCTTTCACCTGACCCATCTTCCTACCTGT 5361 CTGGTCTGACCTGCCCTCTTTGAAAGCACTCATCACCTAGTTTTACTAGGCTGATTGGCAGATGTGGACATGACAGGTGT 5441 CTATCGAGATAGGTGTCTAACTAGTTAGGTGTCTCAGGATTGGACAGCAGAATACCATTCCAGGGGTGCACAGACAGGCC 5521 TCTCCTACCGGAACATGAGGGATAGACGTCTGGGCATTCTGAACCCAGAGGTCAGAGTAGTCACAAGCGGAGCCCTGGGG 5601 AGCGAGGGCCCCAGGGCCGTGGTGTTCCTTGCCCTGCGCTCACTGAAGTCCAAGGCCAGGTTTCAGAAATAGTGTGCTGC 5681 CTGTTCCTGAGATCCTTCACACCTGGACACCAACCCAGACAAAGCCTGACTTAAAATTTTGATACTGTATTCATCGTGGA 5761 ATTTTTCAATAACTCTGATTTTTAAAAAATACTGCATTGCAATATGATTTACCTTGATTACTGAGGCTCTTTTTTTTTTG 5841 GCACCCCTTTAAATTTTAACCCAAGGTGAGGGCCTCACTCCACTCTATACCCAGCCCTGCCTGCCCCTCACCTGGACCTG 5921 TGAGAGGGGCTTAGGTACCACTGTGAAATACGTTTTAAATTTTTACTTGCCCTTCCCCTCAGGTCCTGAGTGAGGCAGTG 6001 GCTCTCTGGCGGTGCTCGCATTTAAATAGGAGTGTGTAGGCTTACAGCAATGAAACATCTAGGAGCTTTTAACTTTGGAT 6081 CTATACCTGGGTGTGACATTTCCTTGGTGTTCTCTGGCTGCCTTTCTGGCTCTGCAGCCCTGAGGGCACTTGTGTGTGTG 6161 TGTGTTCTCTGGAGAAGGGAAGTGATTATGGCAGAGAGGCTCCTTTAGATTCTCCTCTTAAACCTCTTTGGAACATGTTT 6241 GAATTCCAGAAGTGAATGAACTTCATTCATTCTCTCGTCCAGATTTCAGAAGGGACTAAAGTGAACGGAGGCTTTTTCAC 6321 TCCCTGGCATGCTAAGAGCCACATTCCCTAGCTCTGTGCCTGCACAGTGAGTCTTCAGAATTTGGCCCATCACACCCTCT 6401 GCTAGTATCGTTTCCACCACCCTCCTCATCCTCTGTCATCTTTATTTCATTCTCATCGTTTATCTCTACCTCCAGTTCAG 6481 ATGCCATGCTGGCTGTGGCTCTTTTCTTCATCACCATCAGAGTGAGGCAAAGATGTATCCTGGCCTAGTTATAAAGACGA 6561 ATAATACATGATAAGAAATCATTAATTTTTTTCCACGTGGGGGGCGGTGCTGTCCTAGTGATTCATATATATATAATTTT 6641 TGACTCCTTACAATAATTCTGGGATGTGGGTATTACCCCCATTTAAGAATGTGGAAACCAAGGCTCTGATGGCTCTGTAA 6721 TTTGCCCAGGGTCACACAGCTAGGAAGCAAGTTGCTGATCTGCTTGGTTCCAAAGTCACCTCTCTTTTTCCTCTGAGCAC 6801 ATTTCTAAGCCACTACTTAGAAGCTCTTGAGATAAAGTTGGCCTAGCTCAGGTCCACCGAGGTTTTGAGATTGCCCTTTG 6881 CCCAAGGAGGAGTTGTGTCCTTGGCTCACCTGTCATCTGCCTGTGACTGGACTTGAACCCTCGCACGTCTCAGCTGACAT 6961 CCTTGATGCTGCTGGCTGCCTTCCTCGCCCTGTTTCCTCTCCATGACTCCAGGGGTTTGAAGCACACAGGAGCTGGACAT 7041 GTCAATTCTGTAGCTCTTCTCCCAATACCACTGAAGGCCGTGAGCCTCTCTCCTGTTTCCAGCCTGCAGGTGCCCTGTTG 7121 CTGCTCTTCATTCCAGCTTCTCCTCACTTTTCTCTCAGTCTCTTGAGCTTGGAAGCCTTATTGTAGCTTGTGTCTCCTCC 7201 CTGGGCACTTGAGGTCAGGCTTTTGCCTTTTTGTCACATTGAGCCACATGCCTTTGATACACAGTTGTAGCAAAGAAGGG 7281 AGGTGATGAACTTGCTCACTTTCTTTTCTGATTTCCCTCCCTACTCATCCTGCACTCCCCACCGAAACCCAGATATCTTA 7361 TAGTCTAAGGCTTGTAGAGGATTAAGGAAAGGAATTGGAGATGGGTTTTACTTAGTTCACAGAAAAGCTTTCTTTGGGAT 7441 TTTTCCTCCCCCTTAGGGCTTTTAAGTCTAGGTGAAGTGAAAGTTCACACATGTGTTTGTTTGGTTGCTCTGTAATTAGC 7521 TACTAGTTTTTATCCCTAGACCTTCTCTGCTCCAGTGTCTTGTTCATGTGTCCTGACCCCGTGTCCTTGAATTCCCACTT 7601 TGCTTTGGGATTTAAGTTATTGTATGTTGTCAACAATATTTAAAGATGAAAAAGTCCTGAAGGAAACTTACCAGGTTCTT 7681 TCCTTTGGCTTTTTTTTTTTTTTCTTTCGAGGTACTGTAAATTGTTAACTAGGGATGCCAAGCAGGCTTGGTTCAATGGC 7761 TAAACCTCTTATTGTATTACAGTGTAATGCTGATCTCAGCCTGGTCTCAATGCCAGAGCACACAGAGACTTGAATAAAAC 7841 TGTTATAACGATTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HeLa |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Chi_124A_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell miR-124 + A
HITS-CLIP data was present in Chi_ControlA_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell Control A
... - Chi SW; Zang JB; Mele A; Darnell RB, 2009, Nature. |
Article |
- Chi SW; Zang JB; Mele A; Darnell RB - Nature, 2009
MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 6-8 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.
LinkOut: [PMID: 19536157]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084040. RNA binding protein: AGO2. Condition:CLIP_noarsenite_rep1
HITS-CLIP data was present in GSM1084041. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep1
HITS-CLIP data was present in GSM1084043. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep2
HITS-CLIP data was present in GSM1084044. RNA binding protein: AGO2. Condition:CLIP_noarsenite_rep3
HITS-CLIP data was present in GSM1084045. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep3
HITS-CLIP data was present in GSM1084046. RNA binding protein: AGO2. Condition:CLIP_noarsenite_rep4
HITS-CLIP data was present in GSM1084047. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep4
HITS-CLIP data was present in GSM1084064. RNA binding protein: AGO2. Condition:CLIP_noemetine_AbnovaAb
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
HITS-CLIP data was present in GSM1084066. RNA binding protein: AGO2. Condition:CLIP_noemetine_SantaCruzAb
HITS-CLIP data was present in GSM1084067. RNA binding protein: AGO2. Condition:CLIP_emetine_SantaCruzAb
HITS-CLIP data was present in GSM1084068. RNA binding protein: AGO2. Condition:CLIP_noemetine_SigmaAb
HITS-CLIP data was present in GSM1084069. RNA binding protein: AGO2. Condition:CLIP_emetine_SigmaAb
HITS-CLIP data was present in GSM1084072. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep1_AbnovaAb
HITS-CLIP data was present in GSM1084073. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_AbnovaAb
HITS-CLIP data was present in GSM1084074. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep1_SantaCruzAb
HITS-CLIP data was present in GSM1084075. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_SantaCruzAb
HITS-CLIP data was present in GSM1084076. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep1_SigmaAb
HITS-CLIP data was present in GSM1084077. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_SigmaAb
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084080. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SantaCruzAb
HITS-CLIP data was present in GSM1084081. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SantaCruzAb
HITS-CLIP data was present in GSM1084082. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SigmaAb
HITS-CLIP data was present in GSM1084083. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SigmaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cardiac Tissues |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202476. RNA binding protein: AGO2. Condition:S1_LV_54yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset Chi_124A_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell miR-124 + A |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset Chi_ControlA_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell Control A |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084040 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noarsenite_rep1 |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUGUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1084041 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep1 |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1084043 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep2 |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUGUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1084044 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noarsenite_rep3 |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1084045 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep3 |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1084046 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noarsenite_rep4 |
Location of target site | ENST00000554752.2 | 3UTR | UGCAGAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1084047 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep4 |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM1084064 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_AbnovaAb |
Location of target site | ENST00000554752.2 | 3UTR | UGCAGAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000554752.2 | 3UTR | AGAAAAGUGUGUGUGUGUGUGUGUGUGAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1084066 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_SantaCruzAb |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM1084067 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SantaCruzAb |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 14 for dataset GSM1084068 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_SigmaAb |
Location of target site | ENST00000554752.2 | 3UTR | GCAGAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 15 for dataset GSM1084069 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SigmaAb |
Location of target site | ENST00000554752.2 | 3UTR | AGAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 16 for dataset GSM1084072 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep1_AbnovaAb |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 17 for dataset GSM1084073 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep1_AbnovaAb |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 18 for dataset GSM1084074 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep1_SantaCruzAb |
Location of target site | ENST00000554752.2 | 3UTR | AAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 19 for dataset GSM1084075 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep1_SantaCruzAb |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 20 for dataset GSM1084076 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep1_SigmaAb |
Location of target site | ENST00000554752.2 | 3UTR | AGAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 21 for dataset GSM1084077 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep1_SigmaAb |
Location of target site | ENST00000554752.2 | 3UTR | UGCAGAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 22 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000554752.2 | 3UTR | AGAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 23 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000554752.2 | 3UTR | AGAAAAGUGUGUGUGUGUGUGUGUGUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 24 for dataset GSM1084081 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SantaCruzAb |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 25 for dataset GSM1084082 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_SigmaAb |
Location of target site | ENST00000554752.2 | 3UTR | GAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 26 for dataset GSM1084083 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SigmaAb |
Location of target site | ENST00000554752.2 | 3UTR | UGCAGAAAAGUGUGUGUGUGUGUGUGUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
296 hsa-miR-4793-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT092332 | EDEM1 | ER degradation enhancing alpha-mannosidase like protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT131237 | ATG2A | autophagy related 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT145926 | ANKFY1 | ankyrin repeat and FYVE domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT206559 | SOCS5 | suppressor of cytokine signaling 5 | ![]() |
![]() |
2 | 8 | ||||||
MIRT226455 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT337662 | ZNF695 | zinc finger protein 695 | ![]() |
![]() |
2 | 2 | ||||||
MIRT405828 | SIX4 | SIX homeobox 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455113 | RILPL1 | Rab interacting lysosomal protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456756 | TMEM239 | transmembrane protein 239 | ![]() |
![]() |
2 | 4 | ||||||
MIRT457974 | RGS9BP | regulator of G protein signaling 9 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT458173 | LYRM4 | LYR motif containing 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT458245 | SLC9A7 | solute carrier family 9 member A7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466145 | TMEM120B | transmembrane protein 120B | ![]() |
![]() |
2 | 2 | ||||||
MIRT474981 | KATNAL1 | katanin catalytic subunit A1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475601 | HMGB2 | high mobility group box 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT480759 | BMP3 | bone morphogenetic protein 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT481156 | AVL9 | AVL9 cell migration associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT482155 | AK2 | adenylate kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488386 | VAV3 | vav guanine nucleotide exchange factor 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT496575 | KIF18B | kinesin family member 18B | ![]() |
![]() |
2 | 2 | ||||||
MIRT498411 | TXNDC16 | thioredoxin domain containing 16 | ![]() |
![]() |
2 | 4 | ||||||
MIRT504547 | ZNF417 | zinc finger protein 417 | ![]() |
![]() |
2 | 6 | ||||||
MIRT505417 | TCF7L2 | transcription factor 7 like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT509349 | ALDH9A1 | aldehyde dehydrogenase 9 family member A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512164 | CD164 | CD164 molecule | ![]() |
![]() |
2 | 6 | ||||||
MIRT517238 | PRIM1 | DNA primase subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT518671 | KCNMB1 | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519298 | MLH1 | mutL homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT523662 | FOSL2 | FOS like 2, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT525452 | GPATCH2L | G-patch domain containing 2 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT539847 | ZNF766 | zinc finger protein 766 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540076 | SSH3 | slingshot protein phosphatase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540320 | PIGR | polymeric immunoglobulin receptor |